Diabetes Risk Scores in 2011 risk factors, Diabetes Care, 1997;20:491–6.
22. Makrilakis K, Liatis S, Grammatikou S, et al., Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study, Diabet Med, 2010;27:459–65.
23. Bergmann A, Li J, Wang L, et al., A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population, Horm Metab Res, 2007;39:677–82.
24. Schmidt MI, Duncan BB, Bang H, et al., Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study, Diabetes Care, 2005;28:2013–8.
25. Aekplakorn W, Bunnag P, Woodward M, et al., A risk score for predicting incident diabetes in the Thai population, Diabetes Care, 2006;29:1872–7.
26. Simmons RK, Harding AH, Wareham NJ, Griffin SJ; EPIC- Norfolk Project Team, Do simple questions about diet and physical activity help to identify those at risk of type 2 diabetes?, Diabet Med, 2007;24:830–5.
27. Schulze MB, Hoffmann K, Boeing H, et al., An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes, Diabetes Care, 2007;30:510–5.
28. Wilson PW, Meigs JB, Sullivan L, et al., Prediction of incident diabetes mellitus in middle aged adults: the Framingham Offspring Study, Arch Intern Med, 2007;167:1068–74.
29. Kahn HS, Cheng YJ, Thompson TJ, et al., Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years, Ann Intern Med, 2009;150:741–51.
30. Hippisley-Cox J, Coupland C, Robson J, et al., Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore, BMJ, 2009;338:812–6. 31. Sun F, Tao Q, Zhan S, An accurate risk score for estimation
5-year risk of type 2 diabetes based on a health screening population in Taiwan, Diabetes Res Clin Pract, 2009;85:228–34.
32. Gao WG, Qiao Q, Pitkäniemi J, et al., Risk prediction models for the development of diabetes in Mauritian Indians, Diabet Med, 2009;26:996–1002.
33. Rosella LC, Manuel DG, Burchill C, et al., A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT), J Epidemiol Community Health, 2010; Epub ahead of print.
34. Rathmann W, Kowall B, Heier M, et al., Prediction models for incident Type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study, Diabet Med, 2010;27:1116–23.
35. Chen L, Magliano DJ, Balkau B, et al., Maximising efficiency and cost-effectiveness of type 2 diabetes screening: the AusDiab study, Diabet Med, 2011;28:414–23.
36. Glümer C, Vistisen D, Borch-Johnsen K, et al., Risk scores for type 2 diabetes can be applied in some populations but not all, Diabetes Care, 2006;29:410–4.
37. Witte DR, Shipley MJ, Marmot M, Brunner EJ, Performance of existing risk scores in screening for undiagnosed diabetes: an external validation study, Diabet Med, 2010;27:46–53.
38. Cameron AJ, Sicree RA, Zimmet PZ, et al., Cut-points for waist circumference in Europids and South Asians, Obesity, 2010;18:2039–46.
39. Stern MP, Williams K, Haffner SM, Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?, Ann Intern Med, 2002;136:575–81.
40. Kolberg JA, Jørgensen T, Gerwien RW, et al., Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort, Diabetes Care, 2009;32:1207–12.
41. Meigs JB, Multiple biomarker prediction of type 2 diabetes, Diabetes Care, 2009;32:1346–8.
42. Salomaa V, Havulinna A, Saarela O, et al., Thirty-one novel biomarkers aspredictors for clinically incident diabetes, PLoS One, 2010;5:e10100.
43. Meigs JB, Shrader P, Sullivan LM, et al., Genotype score in addition to common risk factors for prediction of type 2 diabetes, N Engl J Med, 2008;20;359:2208–19.
44. Talmud PJ, Hingorani AD, Cooper JA, et al., Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study, BMJ, 2010;340:b4838.
45. Riaz S, Alam SS, Akhtar MW, Proteomic identification of human serum biomarkers in diabetes mellitus type 2, J Pharm Biomed Anal, 2010;51:1103–7.
46. Gross RW, Han X, Lipidomics in diabetes and the metabolic syndrome, Methods Enzymol, 2007;433:73–90.
47. Suhre K, Meisinger C, Döring A, et al., Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting, PLoS One, 2010;5:e13953.
48. Coronary Risk Handbook: Estimating Risk of Coronary Heart Disease in Daily Practice, New York, NY: American Heart Association, 1973:1–35.
49. Wilson PW, Bozeman SR, Burton TM, et al., Prediction of first events of coronary heart disease and stroke with consideration of adiposity, Circulation, 2008;118:124–30.
50. Conroy RM, Pyorala K, Fitzgerald AP, et al., Estimation of ten- year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J, 2003;24:987–1003.
51. Empana JP, Tafflet M, Escolano S, et al., Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R, the Three City, the PRIME and the
SU.VI.MAX studies, Eur J Cardiovasc Prev Rehabil, 2011;18:175–85.
52. Chen L, Tonkin AM, Moon L, et al., Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart, Eur J Cardiovasc Prev Rehabil, 2009;16:562–70.
EUROPEAN ENDOCRINOLOGY
23
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68